project id: TCGA-LUAD; case submitter id: TCGA-38-A44F; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; rna integrity number: 7.5; age at index: 80; days to birth: -29534; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1932; age at diagnosis: 29534; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 133.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8550/3; primary diagnosis: Acinar cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; years smoked: 12.0; is ffpe: false; composition: Not Reported; days to collection: 127; days to sample procurement: 0; initial weight: 580.0; portion submitter id: TCGA-38-A44F-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 8.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 5.0; percent stromal cells: 35.0; percent tumor cells: 60.0; percent tumor nuclei: 80.0;